Product Information

ATORVASTATIN 80 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0700 per EA under NDC 82009017910. Its NADAC has been published 34 times since Nov 5, 2025.

The Low Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ATORVASTATIN 80 MG TABLET

ATORVASTATIN CALCIUM
$0.0700per EA
Low Outlier

Strength

80 mg/1

NDC

82009017910

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214344

On Market Since

8/1/2025

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 80 MG TABLET has been published 34 times since Nov 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0700 per EA
All-time high$0.0726 (Jan 14, 2026)
All-time low$0.0700 (Jun 17, 2026)
52-week high$0.0726
52-week low$0.0700
Median price$0.0715
Average price$0.0715
Largest weekly change+2.0% (Dec 17, 2025)
Weeks tracked34
Tracking sinceNov 5, 2025

Price History

1W

0.0%

1M

-0.8%

3M

-2.0%

6M

-3.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.8%

Generic Alternatives

The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 80 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0700 per EA (NDC 82009017910), effective Jun 24, 2026.

How has the price of ATORVASTATIN 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 80 MG TABLET has held within roughly two percent of its current level. It has been tracked across 34 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 80 MG TABLET?

Since Nov 5, 2025, the NADAC for ATORVASTATIN 80 MG TABLET has ranged from a low of $0.0700 (Jun 17, 2026) to a high of $0.0726 (Jan 14, 2026), with a median of $0.0715 per EA.

Are there cheaper alternatives to ATORVASTATIN 80 MG TABLET?

Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ATORVASTATIN 80 MG TABLET, is $0.0635 per EA — about 9% below ATORVASTATIN 80 MG TABLET.

Who manufactures ATORVASTATIN 80 MG TABLET?

ATORVASTATIN 80 MG TABLET (NDC 82009017910) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.